Patent ID: 9284291
Filing Date: 2016-03-15
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A method of treatment of a disorder or condition selected from the group consisting of depression, mood disorders, schizophrenia, anxiety and addiction, the method comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: X or X R5, R6 and R7 are independently selected from the list consisting of H, C R5 and R6, taken together with the N—C═N group to which they are attached, form a 5-10 membered cyclic or bicyclic ring, optionally substituted with up to two additional heteroatoms selected from the group consisting of N, O and S; or R6 and R7 taken together with the nitrogen atom to which they are attached form a 5-10 membered cyclic or bicyclic ring, optionally substituted with up to two additional heteroatoms selected from the group consisting of N, O and S, and comprising the rings azetidine, pyrrolidine, piperidine, azepine, piperazine, morpholine and thiomorpholine; X R1 and R2 are independently hydrogen or methyl; R3 is hydrogen; and n is zero, one or two.